Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvsv.2012.10.031 | DOI Listing |
Ann Vasc Surg
November 2015
The Vascular Group of Naples, PLC, Naples, FL.
Background: Deep vein thrombosis (DVT) occurs in up to 600,000 patients in the United States annually and can lead to long-term morbidity because of the post-thrombotic syndrome. The multicenter isolated-pharmacomechanical thrombolysis device (ISOL-8) study was designed to determine the safety and efficacy of the Trellis™-8 peripheral infusion system when used as the primary intervention to achieve DVT thrombolysis in patients with proximal lower-extremity occlusive DVT, and track the incidence and severity of the post-thrombotic syndrome (PTS) symptoms in patients 2 years after treatment.
Methods: Data were collected retrospectively from 6 centers on patients treated with the Trellis-8 system, an isolated-pharmacomechanical thrombolysis device (IPMTD).
J Vasc Surg Venous Lymphat Disord
January 2013
Southern Ohio Surgical Associates, Portsmouth, Ohio.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!